Search

Displaying results 8691 - 8700 of 10000 in total
  1. Drug

    UV1

    go.drugbank.com/drugs/DB18470
    Experimental

    UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit

  2. Drug

    Emerfetamab

    go.drugbank.com/drugs/DB18474
    Investigational

    Emerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor.

  3. Drug

    ISB 1442

    go.drugbank.com/drugs/DB18475
    Investigational

    ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47

  4. Drug

    BCX10013

    go.drugbank.com/drugs/DB18496
    Investigational

    BCX10013 is a small molecule inhibitor of human complement factor D.

  5. Drug

    BBP-671

    go.drugbank.com/drugs/DB18498
    Investigational

    BBP-671 is a small molecule activator of pantothenate kinases.

  6. Drug

    MDR-101

    go.drugbank.com/drugs/DB18513
    Investigational

    MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells

  7. Drug

    DSP-5336

    go.drugbank.com/drugs/DB18514
    Investigational

    DSP-5336 is a menin inhibitor.

  8. Drug

    Lusacomfar Alfa

    go.drugbank.com/drugs/DB18526
    Experimental

    Lusacomfar Alfa is a recombinant complement factor H

  9. Drug

    CER-001

    go.drugbank.com/drugs/DB18538
    Investigational

    CER-001 is a negatively charged lipoprotein particle comprising human recombinant apolipoprotein A-I and two phospholipids: sphingomyelin and dipalmitoylphosphatidylglycerol.

    Categories: Apolipoproteins ASynonyms: Recombinant human apolipoprotein A-I/phospholipid complexes
  10. Drug

    SNP-ACTH (1-39)

    go.drugbank.com/drugs/DB18544
    Investigational

    SNP-ACTH (1-39) is a synthetic porcine Corticotropin (ACTH)